Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice
Colorectal cancer ranks as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths globally. Fluoroquinolones, particularly Levofloxacin, have garnered interest for their potential anti-cancer effects, primarily due to their high affinity for metalli...
Main Authors: | Mohammed K Tarab, Falah M AL-Rekabi |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Baghdad, College of Veterinary Medicine
2022-12-01
|
Series: | The Iraqi Journal of Veterinary Medicine |
Subjects: | |
Online Access: | https://jcovm.uobaghdad.edu.iq/index.php/Iraqijvm/article/view/1554 |
Similar Items
-
The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)—First Identifiable Precursors of Colorectal Cancer (CRC)
by: Marek Kowalczyk, et al.
Published: (2020-12-01) -
The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci
by: Marek Kowalczyk, et al.
Published: (2022-11-01) -
A Case of Listeria monocytogenes Bacteremia Treated with Levofloxacin
by: Ferit ÇELİK, et al.
Published: (2014-12-01) -
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
by: Manuel López-López, et al.
Published: (2019-01-01) -
Intracranial hypertension secondary to levofloxacin-therapy
by: Jamir Pitton Rissardo, et al.
Published: (2019-01-01)